95 related articles for article (PubMed ID: 4317645)
21. [Intra-arterial infusion chemotherapy of cisplatin (CDDP)-lipiodol suspension using implantable injection port for unresectable liver cancer patients].
Aogi K; Sawamura A; Funakoshi M; Toge T
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1485-8. PubMed ID: 7690535
[TBL] [Abstract][Full Text] [Related]
22. Cancers of the large bowel and hepatobiliary tract.
Vaughn D; Treat J
Cancer Chemother Biol Response Modif; 1994; 15():508-20. PubMed ID: 7779595
[No Abstract] [Full Text] [Related]
23. Mitoxantrone, 5-FU + folinic acid, mitomycin C for regional chemotherapy of malignant liver tumors.
Link KH; Pillasch J; Weindel M; Leder G; Beger HG
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1380. PubMed ID: 8854758
[No Abstract] [Full Text] [Related]
24. Primary cancer of the liver: a review of 25 cases and report of two prolonged survivals.
White WD; Juniper K
South Med J; 1972 Jan; 65(1):45-8. PubMed ID: 4333468
[No Abstract] [Full Text] [Related]
25. [Study in man of recirculation and tissue uptake of 5-FU 6 H3].
Bessot M; Duprez A; Mauuary G; Winsback AM
Biol Gastroenterol (Paris); 1971; 1():71-7. PubMed ID: 4327245
[No Abstract] [Full Text] [Related]
26. Oral fluorouracil therapy of hepatoma.
Kennedy PS; Lehane DE; Smith FE; Lane M
Cancer; 1977 May; 39(5):1930-5. PubMed ID: 192440
[TBL] [Abstract][Full Text] [Related]
27. [Expression of tumor necrosis factor receptor on peripheral blood mononuclear cells from patients with primary hepatocellular carcinoma and effects of treatment on the expression].
Bai L; Huang CW; Gao L; Jiang B; Nan QZ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1099-100. PubMed ID: 12480583
[TBL] [Abstract][Full Text] [Related]
28. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
[TBL] [Abstract][Full Text] [Related]
29. [The study of continuous infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with primary liver cancer].
Takao T; Nishida M; Maeda Y; Takao K; Oka M
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1724-7. PubMed ID: 9382516
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
[TBL] [Abstract][Full Text] [Related]
31. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Melia WM; Westaby D; Williams R
Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
[No Abstract] [Full Text] [Related]
32. [The chemotherapy for hepatocellular carcinoma].
Nagano H; Sakon M; Monden M
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1895-900. PubMed ID: 14650956
[TBL] [Abstract][Full Text] [Related]
33. [Comments on the treatment of solid tumors with 5-fluorouracil].
Alberto P
Ther Umsch; 1969 Jul; 26(7):415-21. PubMed ID: 4308282
[No Abstract] [Full Text] [Related]
34. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
[TBL] [Abstract][Full Text] [Related]
35. [Study of continuous arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with hepatocellular carcinoma].
Takao T; Nisida M; Maeda Y; Mori N; Tamesa T; Tangoku A; Oka M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1836-40. PubMed ID: 10560407
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Ohya T; Kikuchi S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1623-7. PubMed ID: 6191720
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
38. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous porphyria due to a malignant primary hepatoma.
Thompson RP; Nicholson DC; Farnan T; Whitmore DN; Williams R
Gastroenterology; 1970 Nov; 59(5):779-83. PubMed ID: 4319877
[No Abstract] [Full Text] [Related]
40. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
